2025 Parasitology Workshop - Insights
This interactive workshop will provide hands-on laboratory experiences and presentations by subject matter experts on the laboratory identification of common and esoteric protozoan, helminth, and arthropod parasites. Offering an algorithmic...
2025 Parasitology Workshop - Insights
This interactive workshop will provide hands-on laboratory experiences and presentations by subject matter experts on the laboratory identification of common and esoteric protozoan, helminth, and arthropod parasites. Offering an algorithmic...
2025 Parasitology Workshop - Insights
This interactive workshop will provide hands-on laboratory experiences and presentations by subject matter experts on the laboratory identification of common and esoteric protozoan, helminth, and arthropod parasites. Offering an algorithmic...
Novel biomarkers added to movement disorders profile - Insights
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' expanded movement disorders panel better identifies autoimmune conditions to guide appropriate treatment.
Skip to Content MayoACCESS MayoLINK...
On Demand Education organized by MLS credit categories.
Future Direction of Lab Medicine - Insights
Looking into the future of laboratory medicine and pathology and providing insight into the direction its heading.
The following on demand education is related to the “Other” category in medical laboratory science (MLS), which encompasses a variety of specialized topics and emerging areas that don’t fall into traditional categories like hematology,...
Saving and improving lives: The illuminating journey of a laboratory testing specimen - Insights
Check out the first episode of “Life of a Specimen,” a video series that examines the critical journey taken by patient samples through Mayo Clinic Laboratories testing. In this video, we learn about the profound impact of our testing on...
MayoComplete Solid Tumor Panel - Insights
Kevin Halling, M.D., Ph.D., explains how the MayoComplete Solid Tumor panel uses next-generation sequencing to assess 514 clinically significant, cancer-related genes for genetic alterations that offer insight on treatment effectivity.